Karus Therapeutics

Developer of oral small molecule inhibitors to treat multiple diseases

placeAbingdon, England, United Kingdom calendar_todayFounded 2005 groups8 employees language karustherapeutics.com

Registered entities

Innovation

56 patent families (19 granted) — focus: Chemistry & metallurgy, Human necessities, Emerging technologies; filing pace slowing. Cited 3,364 times.

YearFilings
20126
20138
201411
201515
20167
201715
201814
201916
20209
20216
20223
20231

Investor mix

8 investors on record; lead investors include SV Health Investors.

Investor typeCountShare
Venture capital450%
Accelerator & incubator113%
Bank & private debt113%
Other / undisclosed225%
Coming soon